Negative regulation of the major histocompatibility complex class I promoter in embryonal carcinoma cells.
- 15 April 1991
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 88 (8) , 3145-3149
- https://doi.org/10.1073/pnas.88.8.3145
Abstract
Transcription of major histocompatibility complex (MHC) class I genes is negatively regulated in undifferentiated F9 mouse embryonal carcinoma cells via the conserved upstream regulatory region. This region contains constitutive enhancers and an inducible enhancer, the interferon consensus sequence (ICS), that is responsible for interferon-induced transcription. A series of mutations in the ICS, but not in the enhancer elements, resulted in an increase in expression of the MHC class I promoter in F9 cells. However, these ICS mutants did not increase promoter activity in F9 cells differentiated after retinoic acid treatment. Results of mobility-shift DNA-binding assays and methylation interference experiments showed that undifferentiated F9 cells contained a factor(s) that bound to a sequence within the 5' and central part of the ICS. This binding site, termed the MHC negative regulatory element (NRE), coincided with the site of mutations that increased promoter activity in F9 cells and was distinct from the element to which interferon-response factors bind. The factor(s) that binds to the MHC NRE was not detected in differentiated F9 cells treated with retinoic acid or in other cells expressing MHC class I genes. Finally, introduction of concatenated, double-stranded NRE oligomers, but not oligomers of unrelated sequences, into F9 cells abolished negative regulation of the MHC class I promoter activity, providing evidence that the NRE binding factor is responsible for repression of the MHC class I genes in F9 cells.Keywords
This publication has 35 references indexed in Scilit:
- Developmental and tissue-specific expression of nuclear proteins that bind the regulatory element of the major histocompatibility complex class I gene.The Journal of Experimental Medicine, 1989
- Steroid receptor-mediated inhibition of rat prolactin gene expression does not require the receptor DNA-binding domainCell, 1988
- Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cellsCell, 1986
- Negative regulation of viral enhancers in undifferentiated embryonic stem cellsCell, 1985
- Non-function of a Moloney murine leukaemia virus regulatory sequence in F9 embryonal carcinoma cellsNature, 1984
- Delayed de novo methylation in teratocarcinoma suggests additional tissue-specific mechanisms for controlling gene expressionNature, 1983
- Tumor viruses and early mouse embryosBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1982
- Hormonal induction of differentiation in teratocarcinoma stem cells: Generation of parietal endoderm by retinoic acid and dibutyryl cAMPCell, 1980
- Teratocarcinomas and Mammalian EmbryogenesisScience, 1980
- ABSENCE OF SEROLOGICALLY DETECTABLE H-2 ON PRIMITIVE TERATOCARCINOMA CELLS IN CULTURETransplantation, 1974